ストックスクリーナーアプリを入手
1.845
3.65%
0.065
前日終値:
$1.78
開ける：
$1.8
24時間の取引高:
4,191
Relative Volume:
0.04
時価総額：
$4.11M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+10.48%
1か月 パフォーマンス:
-7.29%
6か月 パフォーマンス:
-82.59%
1年 パフォーマンス:
-96.95%
1日の値動き範囲:
$1.80
$1.8726
1週間の範囲:
$1.61
$1.8799
52週間の値動き範囲:
$1.52
$75.80
Autonomix Medical Inc Stock (AMIX) Company Profile
名前
Autonomix Medical Inc
セクター
電話
832-277-7816
住所
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
AMIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
1.85 | 4.11M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
131.53 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
94.84 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
347.49 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.31 | 106.51B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.47 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Autonomix Medical Inc (AMIX) 最新ニュース
Autonomix Medical announces inducement grant - Medical Buyer
Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Autonomix Medical Expands Team with Strategic 5,000-Share Stock Option Grant to New Key Employee - Stock Titan
Autonomix Medical secures new European patent for nerve tech By Investing.com - Investing.com South Africa
Autonomix Medical Granted European Patent For Catheter-Based Neuromodulation Technology - Nasdaq
Autonomix Medical Gains European Patent for Catheter-Based Tech - Medical Product Outsourcing
Autonomix Medical secures new European patent for nerve tech - Investing.com
Autonomix Medical Granted New European Patent For Proprietary Catheter-Based Technology - marketscreener.com
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology - GlobeNewswire
Medical Breakthrough: Autonomix's New EU Patent Powers Multi-Condition Treatment Platform - Stock Titan
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline - Investing.com Australia
Autonomix stock plunges to 52-week low of $1.52 amid steep annual decline By Investing.com - Investing.com South Africa
Analyzing Globus Medical (NYSE:GMED) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix to begin U.S. clinical studies for FDA approval By Investing.com - Investing.com South Africa
Autonomix to begin U.S. clinical studies for FDA approval - Investing.com
Autonomix Medical, Inc. Engages Leading Medical Experts to - GlobeNewswire
Top Medical Experts Join Forces to Advance Revolutionary Pancreatic Cancer Pain Treatment - Stock Titan
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) - GlobeNewswire
Revolutionary Pancreatic Cancer Pain Treatment: Autonomix Medical Reveals First Clinical Results at ECIO 2025 - Stock Titan
Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update - Defense World
Patent Granted to Autonomix Medical for Sensing Data Collection - Medical Product Outsourcing
Autonomix stock plunges to 52-week low of $1.81 amid market challenges By Investing.com - Investing.com South Africa
Autonomix stock plunges to 52-week low of $1.81 amid market challenges - Investing.com Australia
Financial Analysis: INVO Bioscience (NASDAQ:INVO) & Autonomix Medical (NASDAQ:AMIX) - Defense World
Autonomix Medical announces inducement grant under Nasdaq listing rule 5635(C)(4) - Marketscreener.com
Autonomix Medical Awards Strategic Stock Options Package Under Nasdaq Rules - StockTitan
Can Autonomix Sensing And RF Ablation System Prove Its Mettle In Managing Pancreatic Cancer Pain? - RTTNews
Autonomix Medical Granted US Patent for Catheter-Based Technology; Shares Up 10% Pre-Bell - Marketscreener.com
Autonomix Medical Expands Patent Portfolio with New Issuance for Innovative Sensing and Ablation Technology - Nasdaq
Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology - The Manila Times
Autonomix Medical, Inc. Granted U.S. Patent Covering - GlobeNewswire
Groundbreaking Patent: Autonomix Medical's New Tech 3000x More Sensitive Than Current Solutions - StockTitan
Head to Head Analysis: Autonomix Medical (NASDAQ:AMIX) versus SI-BONE (NASDAQ:SIBN) - Defense World
Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest - Defense World
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix advances pancreatic cancer treatment system - Investing.com Australia
Autonomix Medical Advances Toward US Clinical Trials In 2025 With Apex 6 Generator Integration - Nasdaq
Autonomix advances toward U.S. clinical trials in 2025 - TipRanks
Autonomix advances pancreatic cancer treatment system By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation - The Manila Times
Autonomix Medical Achieves Design Lock for Apex 6 Radiofrequency Generator, Advances Towards U.S. Clinical Trials for Pancreatic Cancer Pain Treatment - Nasdaq
Autonomix Medical, Inc. Advances Toward U.S. Clinical - GlobeNewswire
Autonomix Achieves Critical Milestone: FDA-Cleared Technology Powers New Cancer Pain Treatment System - StockTitan
Autonomix stock plunges to 52-week low of $2.23 amid market challenges - Investing.com Australia
Autonomix stock plunges to 52-week low of $2.23 amid market challenges By Investing.com - Investing.com South Africa
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Autonomix Medical, Inc. Announces Abstract Highlighting Technology And Early Proof-Of-Concept Study Results Accepted At The Society Of Interventional Radiology (SIR) Annual Scientific Meeting - MENAFN.COM
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - GlobeNewswire
Autonomix Medical Inc (AMIX) 財務データ
Autonomix Medical Inc (AMIX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.85%
0.85%
大文字化:
|
ボリューム (24 時間):